BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 952 filers reported holding BAXTER INTL INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,813 | -17.2% | 366 | 0.0% | 0.00% | – |
Q2 2023 | $16,675 | +12.3% | 366 | 0.0% | 0.00% | – |
Q1 2023 | $14,845 | +185462.5% | 366 | +120.5% | 0.00% | – |
Q4 2022 | $8 | -99.9% | 166 | -11.7% | 0.00% | – |
Q3 2022 | $10,000 | -85.5% | 188 | -82.4% | 0.00% | -100.0% |
Q2 2022 | $69,000 | -14.8% | 1,068 | +2.1% | 0.00% | 0.0% |
Q1 2022 | $81,000 | -10.0% | 1,046 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $90,000 | +7.1% | 1,046 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $84,000 | -22.9% | 1,046 | -22.6% | 0.00% | -33.3% |
Q2 2021 | $109,000 | -4.4% | 1,351 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $114,000 | +2.7% | 1,351 | -2.0% | 0.00% | -25.0% |
Q4 2020 | $111,000 | +1.8% | 1,378 | +2.0% | 0.00% | 0.0% |
Q3 2020 | $109,000 | -6.0% | 1,351 | 0.0% | 0.00% | -20.0% |
Q2 2020 | $116,000 | -39.3% | 1,351 | -42.5% | 0.01% | -44.4% |
Q1 2020 | $191,000 | -3.0% | 2,351 | 0.0% | 0.01% | +28.6% |
Q4 2019 | $197,000 | +41.7% | 2,351 | +30.1% | 0.01% | +40.0% |
Q3 2018 | $139,000 | -33.8% | 1,807 | -36.6% | 0.01% | -44.4% |
Q2 2018 | $210,000 | +52.2% | 2,850 | -8.5% | 0.01% | -10.0% |
Q4 2016 | $138,000 | -44.6% | 3,116 | -8.4% | 0.01% | -37.5% |
Q4 2015 | $249,000 | 0.0% | 3,400 | 0.0% | 0.02% | -46.7% |
Q4 2014 | $249,000 | -48.7% | 3,400 | -49.3% | 0.03% | -52.4% |
Q2 2014 | $485,000 | -1.8% | 6,710 | 0.0% | 0.06% | -10.0% |
Q1 2014 | $494,000 | +5.8% | 6,710 | 0.0% | 0.07% | 0.0% |
Q4 2013 | $467,000 | +5.9% | 6,710 | 0.0% | 0.07% | -7.9% |
Q3 2013 | $441,000 | – | 6,710 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |